Re: New PR on share buyback
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: New PR on share buyback
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Part of our master agreement with TPL stipulates that they will screen all press releases before submitted by PTSC. Thus the delay and also the lack of information to investors.
"Enlighten me if I am wrong. but I don't believe it makes any sense to link this lack of transparency in this particular case to neither the current litigation in Texas nor the master agreement with TPL".
That was the whole point in what I was saying.
Loading...
Loading...
Sep 28, 2007 09:22AM
New Message
Please
login
to post a reply